
Bioorganic and Medicinal Chemistry Letters p. 1453 - 1458 (1999)
Update date:2022-08-04
Topics:
Duan, James J.-W
Chen, Lihua
Xue, Chu-Biao
Wasserman, Zelda R.
Hardman, Karl D.
Covington, Maryanne B.
Copeland, Robert R.
Arner, Elizabeth C.
Decicco, Carl P.
A novel series of 13- and 14-membered macrocyclic amines was developed by linking the P1 and P2' groups. The synthesis entails stereoselective Frater alkylation to install the anti-succinate configuration and macrocyclic amination via nucleophilic displacement. This strategy resulted in a new class of conformationally constrained inhibitors that are potent and selective for MMP-8 and 9 over MMP-1 and 3.
View MoreTaizhou Crene Biotechnology co.ltd
Contact:86-576-88813233 88205808
Address:Economic Developed Zone of Taizhou Zhejiang China
Jiangsu Willing Bio-Tech Co ltd
website:http://www.willingbio.com/
Contact:+86 18796908173
Address:No 18 Guoqiao Road
Wuhan Kemi-Works Chemical Co., Ltd
website:http://www.kemiworks.com
Contact:86-27-85736489
Address:Rm. 1503, No. 164, Jianghan North Rd., Wuhan, 430022 China
Jiangsu Zenji Pharmaceuticals LTD
Contact:+86-025-83172562; +1-224-888-1133(USA)
Address:No.5 Xinmofan Road
Antaeus Bio-technology Co., LTD(expird)
Contact:021-31252569
Address:shanghai pudong
Doi:10.1039/a607200c
(1997)Doi:10.1021/ja01588a037
(1956)Doi:10.1021/om970211l
(1997)Doi:10.1246/cl.1994.1013
(1994)Doi:10.1021/jo500061w
(2014)Doi:10.1021/ja00097a026
(1994)